Tags: Allergies | allergy | drugs | Ranbaxy | recall | loratadine | pseudoephedrin

Allergy Medication Recalled

Friday, 02 May 2014 12:13 PM

 


Indian drugmaker Ranbaxy Laboratories Ltd started recalling 29,790 packs of an allergy-relief medicine in the United States in February, after finding defects in the packaging, the U.S. Food and Drug Administration said.
The loratadine and pseudoephedrine sulphate extended release tablets being recalled carry an expiry date of September 2015, and were manufactured by Ranbaxy's Ohm Labs plant in New Jersey, which is the company's only facility making generics for the United States.
All other Ranbaxy plants, based in India, have been banned from exporting generics to the United States after the FDA found manufacturing quality glitches that the agency believed could compromise the quality of medicines.
Rival Indian drugmaker Sun Pharmaceutical Industries Ltd agreed to buy Ranbaxy last month in a $3.2 billion deal, betting it can fix Ranbaxy's problems.
The FDA classified the recall by Ohm Labs as Class II, which means use of or exposure to the recalled products may cause temporary or medically reversible adverse health consequences.
Ranbaxy did not immediately respond to requests for comment.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Some Doctors Won't See Patients With Anti-Vaccine Views

Thursday, 29 Jan 2015 17:15 PM

With California gripped by a measles outbreak, Dr. Charles Goodman posted a clear notice in his waiting room and on Face . . .

Scientists Discover Fast Method to Determine Concussion Severity

Thursday, 29 Jan 2015 17:09 PM

A new eye-tracking method might help determine the severity of concussions, researchers report.

They said the . . .

TV Binge-Watching Can Be Sign of Depression: Study

Thursday, 29 Jan 2015 17:03 PM

Binge-watching television is linked with feeling lonely and depressed, a new study suggests.

Even though som . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved